Ronda Kennedy, the Republican candidate for U.S. Congress in CA 26, called for a tax incentive for pharmaceutical companies to move manufacturing operations back to the United States. Kennedy pointed out that the coronavirus pandemic demonstrates the need for drugs to be manufactured inside the United States. She pointed out that during the Obama/ Biden years, the cost of manufacturing drugs in the United States became exorbitant forcing the companies to shift manufacturing operations overseas. The tax incentive proposed by Kennedy would induce pharmaceutical companies to return manufacturing operations stateside resulting in jobs for thousands of Americans, and lessen America’s dependency on foreign countries that do not have our clear America First agenda. Kennedy said Ventura, California is still suffering from the failed Obama/Biden economic policies and would welcome a pharmaceutical manufacturing facility and the jobs it would create.
“The coronavirus pandemic has fully demonstrated the need for pharmaceutical companies to manufacture in the United States,” said Ronda Kennedy. “Sadly, it has not been economically feasible for pharmaceutical companies to do so. I am proposing a tax incentive that will return these operations stateside and create jobs. We need to put the safety and economic well-being of Americans first.
“The exodus of pharmaceutical manufacturing in the United States is a legacy of the Obama/Biden years,” continued Kennedy. “Residents of the 26th District remember those years far too well with record unemployment and foreclosures.”